New Delhi, March 02, 2021: As a huge number of street dogs died due to the canine Parvovirus in West Bengal, the New Delhi-based Company Panav Bio-Tech which is the importer and marketer of ‘Canglob P’, hyperimmune immunoglobulins for Parvovirus, said there is a sudden increase in the demand of the hyperimmune immunoglobulin for dogs.
The company has witnessed an increase in demand for Canglob P after the outbreak of the Parvovirus.
Parvovirus is a highly contagious and deadly viral disease that affects dogs, especially puppies. The mortality rate for this virus is high.
Canine Distemper is highly contagious and potentially fatal. It causes severe illness in the dog by attacking multiple body systems, resulting in widespread infection.
As far as treatment goes, Panav Bio-Tech provides Canglob hyperimmune immunoglobulins that can help in treating dogs who have contracted Parvovirus or Distemper Virus. Both the Canine Parvovirus and Canine Distemper Virus are deadly for dogs. These hyperimmune immunoglobulins are used to provide passive immunity in animals.
Canglob P and Canglob D forte have readymade antibodies for Pre and Post Exposure of Parvovirus and Distemper. It is a definite help to your vet. The earlier the puppies are diagnosed, the faster they receive treatment, the better their chance of recovery.
Sharing the information, Director Import/Marketing of Panav Bio-Tech, Mr. Puneet Chopra said, “We have endeavoured to provide effective vaccination and Canglob hyperimmune immunoglobulins against fatal diseases. Parvovirus is highly contagious and fatal so we request the pet owners to take extra care of their pets. Parvovirus spreads directly through contact with infected dogs and indirectly through infected faeces or vomiting. Since dogs are well-known lickers, they can lick contaminated paws or another infected dog and can cause the disease.”
Newsvoir
Pearson Syndrome is an extremely rare condition and the prevalence is approximately 1 in a…
A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…
People who smoke are also at much higher risk of developing diabetes compared to non-smokers…
17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…
Lonavala, November 12, 2024: As the global cancer burden rises to 30 million cases by…
The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…